Effects of compound herb of invigorating kidney and promoting blood flow on serum matrix metalloproteinases-3, tumor necrosis factor alpha, interleukin-1, hyaluronic acid, lipid peroxidation levels and superoxide dismutase activity in patients with knee osteoarthritis

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 12, Issue 28, 2008, Pages 5436-5439

  Zeng, Yi Rong ^a   Fan, Yue Guang ^a   Wu, Fan ^a   Li, Xian Peng ^a   Fan, Hai Jiao ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGELICA EXTRACT; CARICA PAPAYA EXTRACT; CARTHAMUS EXTRACT; CHINESE DRUG; COSTUS EXTRACT; CYATHULA OFFICINALIS EXTRACT; EUCOMMIA EXTRACT; GUXIAN; HERBACEOUS AGENT; HYALURONIC ACID; INTERLEUKIN 1; LIGUSTICUM CHUANXIONG EXTRACT; LIPID; LYCIUM BARBARUM EXTRACT; PLANT EXTRACT; PSORALEA EXTRACT; REHMANNIA EXTRACT; SALVIA MILTIORRHIZA EXTRACT; STROMELYSIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CHINA; CHINESE HERB; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COSTUS; CYATHULA OFFICINALIS; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; KIDNEY BLOOD FLOW; KNEE OSTEOARTHRITIS; LIPID PEROXIDATION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

CARICA PAPAYA; CYATHULA; EUCOMMIA; FLOS; PSORALEA; REHMANNIA; SALVIA MILTIORRHIZA;

EID: 52949131324     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hollander AP, Heathfied TF, Webber C, et al. Increased damage to type II collagen in osteoarthritic cartilage detected by a new immunoassay. J Clin Invest 1998;93(4):1722-1732
2. Krzeski P, Buckland-Wright C, B á Iint G, et al. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res Ther 2007;9(5):R109
3. Blom AB, van Lent PL, Libregts S, et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum. 2007;56(1):147-157
4. Lohmander LS, Brandt KD, Mazzuca SA, et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum. 2005;52(10):3160-3167
5. Wang AM, Wang BE. Guowai Yixue: Linchuang Shenghua yu Jianyanxue Fence 1995;16(6):246
6. Sondergaard BC, Henriksen K, Wulf H, et al. Relative contribution of matrix metalloprotease and cysteine pmtease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Castilage 2006;14(8):738-748
7. Zeng QY. Tianjin: Tianjin Science Technology Press 1999:18-25
8. Diab M. The role of type IX collagen in osteoarthritis and rheumatoid arthritis. Orthop Rev 1998;222(2):165-170
9. Kobayashi A, Naito S, Enomoto H, et al. Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis. Arch Pathol Lab Med 2007;131(4):563-570
10. Deng LF, Chai BF. Guowai Yixue: Chuangshang yu Waike Jiben Wenti Fence 1996; 17(3):152-155
11. Zhao HB, Du JY. Guowai Yixue: Chuangshang yu Waike Jiben Wenti Fence 1996;17(1):27
12. Kobayashi M, Squires GR, Mousa A, et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005;52(1):128-135
13. Penninx BW, Abbas H, Ambrosius W, et al. Inflammatory markers and physical function among older adults with knee osteoarthritis. Rheumatol 2004;31(10):2027-2031
14. Di Giovine FS, Nuki G. Tumor necrosis factor in synovial exudates. Ann Rheum Dis 1988;47:768-772
15. Takagishi K, Maeda K, Goso Y, et al. Absence of immunty to type II cikkageb abd proteoglycan in osteoarthritic C57BL mice. Inflam Res 1999; 4(5):222-226
16. Botha-Scheepers SA, Watt I, Slagboom E, et al. Innate production of Tumor Necrosis Factor- {alpha} and Interleukin-10 is associated with radiological progression of knee osteoarthritis. Ann Rheum Dis 2007
17. Wang CT, Lin YT, Chiang BL, et al. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 2006;14(12): 1237-1247
18. Torvard CL, Robert EF, Vlla BGL, et al. Hyaluronate in inflammatory joint disease. Acts Orthop Scand 1995;66:116
19. Kalaci A, Yilmaz HR, Aslan B, et al. Effects of hyaluronan on nitric oxide levels and superoxide dismutase activities in synovial fluid in knee osteoarthritis. Clin Rheumatol 2007;26(8):1306-1311
20. Li YM, Yang YD, Chen SX. Zhongguo Zhongxiyi Jiehe Waike Zazhi 2004; 10(3):151-153